Probiotherapy

We believe in the bacterial revolution 3/02/2026  |  Probiotherapy  |  6 min read “Within eighteen months, our YUN products will reach two billion people worldwide,” says our founder & CEO Tom Verlinden. With six unique, globally recognized patent families, the Belgian Niel-based biotech company YUN is the only enterprise in the world to have sparked […]

Why measuring microbial impact matters: inside YUN’s Microbiome Safe Scoring System 22/12/2025  |  Probiotherapy  |  10 min read “Mild is not the same as microbiome-safe. Our scoring system shows the difference. Microbiome safety is measurable and the bacteria tell us the truth.” The rise of microbiome science is reshaping how we formulate, evaluate and validate

Animalcare and YUN announce strategic partnership to lead probiotherapeutical innovation in veterinary medicine 12/12/2025  |  Probiotherapy  |  7 min read Animalcare Group plc, a leading European veterinary pharmaceutical company, and YUN, a Belgian biotech innovator in human probiotherapy, announced a strategic alliance to accelerate the development and commercialisation of microbiome-based veterinary products. This partnership positions

Biotics & the Skin Microbiome: How Probiotics, Prebiotics & Postbiotics are shaping the future of Dermatology 05/12/2025  |  Probiotherapy  |  10 min read “Biotics are no longer a trend — they are the scientific foundation for a new generation of dermatological strategies that restore balance, not destroy it.” At YUN Probiotherapy, we use live probiotics,

Bausch Health Partners with YUN to bring pioneering microbiome skincare to Poland 04/12/2025  |  Probiotherapy  |  7 min read Left: Tom Verlinden, CEO & founder of YUN – Right: Cees Heiman, Senior Vice President, Europe & Canada Bausch Health This strategic partnership introduces new probiotherapy solutions for managing acne-prone skin to the Polish market, with